BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6476819)

  • 21. Evaluation of the antiherpetic activity of acyclovir in rabbits.
    Trousdale MD; Nesburn AB
    Am J Med; 1982 Jul; 73(1A):155-60. PubMed ID: 6285707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adverse side effects caused by topically applied antiviral agents in herpetic keratitis].
    Chen CW
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Aug; 5(8):416-29. PubMed ID: 2480457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of retinoids on the replication of herpes simplex virus type 1.
    Taylor JL; O'Brien WJ
    Curr Eye Res; 1984 Mar; 3(3):481-8. PubMed ID: 6321106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acyclovir in herpes keratitis.
    Collum LM; Logan P; Hillary IB; Ravenscroft T
    Am J Med; 1982 Jul; 73(1A):290-3. PubMed ID: 7102709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of therapeutic activity of idoxuridine and acyclovir in experimentally-induced herpetic keratitis in rabbits (author's transl)].
    Colin C; Chastel C; Quillien MC; Renard G
    J Fr Ophtalmol; 1981; 4(1):33-43. PubMed ID: 7217623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ara-A and IDU therapy of human superficial herpetic keratitis.
    Laibson PR; Hyndiuk R; Krachmer JH; Schultz RO
    Invest Ophthalmol; 1975 Oct; 14(10):762-3. PubMed ID: 1102484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acyclovir in herpes simplex keratitis.
    Falcon MG
    J Infect; 1983 May; 6(1 Suppl):37-40. PubMed ID: 6193206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of topical acyclovir therapy on experimental herpes simplex keratouveitis.
    Maudgal PC; Vrijghem JC; Molemans M; Missotten L
    Arch Ophthalmol; 1985 Sep; 103(9):1389-92. PubMed ID: 3929753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimetabolite drug therapy in herpes simplex.
    Kaufman HE
    Ophthalmology; 1980 Feb; 87(2):135-9. PubMed ID: 6247680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vidarabine therapy of complicated herpes simplex keratitis.
    O'Day DM; Poirier RH; Jones DB; Elliott JH
    Am J Ophthalmol; 1976 May; 81(5):642-9. PubMed ID: 1275044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of 5-iodo-2'deoxyuridine (IDU) and dexamethasone on corneal wound healing in the rabbit.
    Puelhorn G; Sosath G; Thiel HJ
    Acta Ophthalmol (Copenh); 1978 Feb; 56(1):40-52. PubMed ID: 580336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of acyclovir and idoxuridine as treatment for ulcerative herpetic keratitis.
    Coster DJ; Wilhelmus KR; Michaud R; Jones BR
    Br J Ophthalmol; 1980 Oct; 64(10):763-5. PubMed ID: 7000170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2'-Nor-2'-deoxyguanosine is an effective therapeutic agent for treatment of experimental herpes keratitis.
    Davies ME; Bondi JV; Grabowski L; Schofield TL; Field AK
    Antiviral Res; 1987 Feb; 7(2):119-25. PubMed ID: 3495237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study.
    Hoh HB; Hurley C; Claoue C; Viswalingham M; Easty DL; Goldschmidt P; Collum LM
    Br J Ophthalmol; 1996 Feb; 80(2):140-3. PubMed ID: 8814744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [INHIBITION OF EPITHELIAL REGENERATION AND CORNEAL WOUND HEALING IN RABBITS BY ANTIMETABOLITES].
    WOLLENSAK J; KYPKE W
    Albrecht Von Graefes Arch Ophthalmol; 1965 Feb; 168():102-15. PubMed ID: 14267189
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of BW759 (9-[[2-hydroxy-1(hydroxymethyl)ethoxy]methyl]guanine) against herpes simplex virus type 1 keratitis in rabbits.
    Trousdale MD; Nesburn AB; Willey DE; Taaid H
    Curr Eye Res; 1984 Aug; 3(8):1007-15. PubMed ID: 6333319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acyclovir and debridement in the treatment of ulcerative herpetic keratitis.
    Wilhelmus KR; Coster DJ; Jones BR
    Am J Ophthalmol; 1981 Mar; 91(3):323-7. PubMed ID: 7011037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical urea as a treatment for non-infectious keratopathy.
    Charlton JF; Schwab IR; Stuchell R
    Acta Ophthalmol Scand; 1996 Aug; 74(4):391-4. PubMed ID: 8883557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of topically administered platelet-derived growth factor on corneal wound strength.
    Murali S; Hardten DR; DeMartelaere S; Olevsky OM; Mindrup EA; Hecht ML; Karlstad R; Chan CC; Holland EJ
    Curr Eye Res; 1994 Dec; 13(12):857-62. PubMed ID: 7720391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An in vitro study of ophthalmic antiviral agent toxicity on rabbit corneal epithelium.
    Imperia PS; Lazarus HM; Dunkel EC; Pavan-Langston D; Geary PA; Lass JH
    Antiviral Res; 1988 Jul; 9(4):263-72. PubMed ID: 3144240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.